Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Hims & Hers will get to sell Ozempic. Like, real Ozempic. The stock soars 50%
Hims & Hers and the Danish pharma giant Novo Nordisk have ended a bitter legal feud that will allow the telehealth company to sell Novo’s brand name weight loss drugs, sending Hims & Hers stock rocketing more than 50%.
The companies had clashed on and off for months as Hims & Hers marketed compounded versions of Novo Nordisk’s blockbuster GLP-1 drug Wegovy. Novo sued Hims & Hers for patent infringement last month, saying the online site was selling cheaper, unapproved copies of Wegovy.
Related Content
Costco keeps printing money — in bulk
Kroger stock pops on solid earnings, bucking the market’s downward trend
But in statements early Monday, the companies said Hims & Hers would soon sell brand name Wegovy and Novo Nordisk’s other GLP-1 Ozempic on its platform later this month.
Hims & Hers soared as much as 52% in pre-market trading.
“We see tremendous growth opportunities in the U.S. with the expanding assortment of branded GLP-1 medications,” Hims & Hers CEO Andrew Dudum said in a statement. “I’m excited to have a great partner in Novo Nordisk as we work to create a new model that works for everyday people. This collaboration reflects what’s possible globally when drugmakers, biotech companies, and diagnostic leaders partner with consumer platforms to support scaled distribution of their latest medical innovations.”
The companies both said that Hims & Hers would no longer sell compounded versions of the drug, and that Novo Nordisk was dropping its lawsuit as part of the deal.
“We welcome Hims & Hers shifting their GLP-1 business model to focus on increasing access to affordable, branded FDA-approved medicines,” Novo Nordisk said in a statement. “Hims & Hers will no longer advertise compounded GLP-1 offerings on its platform or in its marketing, and existing patients will have the opportunity to transition to FDA-approved alternatives when clinically appropriate in consultation with a healthcare professional.”
Last June, Novo Nordisk said it was ending a previous partnership with Hims & Hers, accusing the telehealth company of “deceptive promotion and selling of illegitimate, knockoff versions” of Wegovy. That sent Hims & Hers stock tumbling.
Novo Nordisk kicked off the weight loss drug boom with Ozempic and Wegovy, but has since lost ground to Eli Lilly $LLY -0.32%.
📬 Sign up for the Daily Brief
Our free, fast and fun briefing on the global economy, delivered every weekday morning.
Sign me up
Top 10 Stocks for 2026Learn about 10 names that score well across growth, value, and profitability.Seeking Alpha |
SponsoredSponsored
Explore
Undo
Buy The Dip: 2 Of The Best Undervalued 8%-10% Yields I’ve SeenMost investors chase growth. These two overlooked income plays offer 8–10% yields at prices that still make sense.Seeking Alpha |
SponsoredSponsored
Read More
Undo
60歳になって聞き返すことが増えた私の最適解！ワンタッチ操作の集音器Olive Union |
SponsoredSponsored
続きを読む
Undo
Beyond Text Generation: An AI Tool That Helps You Write BetterImprove grammar, word choice, and sentence structure everywhere you work. Write better with Grammarly.Grammarly |
SponsoredSponsored
Install Now
Undo
Use an AI Writing Tool That Actually Understands Your VoiceImprove grammar, word choice, and sentence structure everywhere you work. Write better with Grammarly.Grammarly |
SponsoredSponsored
Install Now
Undo
Meet Curvy Women OnlineSeasoned Plus Size Singles: Dating Starts HereFunchatt |
SponsoredSponsored
Read More
Undo
Many women here want a senior dating — join in.While You Wait - They’re Chatting [Try It]GoldenAgeSouls |
SponsoredSponsored
Click Here
Undo
顧客満足度No.1の転職サイトエン転職 |
SponsoredSponsored
Undo
裸眼のままで車外が3D仮想空間に？「窓」が体験を生み出すインターフェースに変わる日経BP × ひとと世界をつなぐ技術の未来 |
SponsoredSponsored
Undo
「窓」が体験を生み出すインターフェースに変わる！裸眼のままで車外が3D仮想空間に日経BP × ひとと世界をつなぐ技術の未来 |
SponsoredSponsored
Undo
Most Luxurious Hotels in the WorldTheseniormag.com |
SponsoredSponsored
Learn More
Undo
Play this game for 1 minute and see why everyone is crazy about itNo Installation. Play for free.planetcapture.io |
SponsoredSponsored
Undo
15 Most Beautiful Women EverPaperela |
SponsoredSponsored
Undo
The woman who sued Donald Trump alleging child rape has called off her press conferenceQuartz
Undo
The rise of the 4-letter baby nameQuartz
Undo
Play this game for 3 minutes, if you own a mouseNo Installation. Play for free.planetcapture.io |
SponsoredSponsored
Undo
入園入学のお祝い・新生活の準備に!おもちゃ・入園入学グッズが勢ぞろいAmazon.co.jp |
SponsoredSponsored
Undo
食の未来を支える選択肢「シュガーエステル」おいしさを長く保ち、流通や加工を支える乳化剤「リョートーシュガーエステル」を紹介します。三菱ケミカル |
SponsoredSponsored
続きを読む
Undo
カメラ・アクセサリーまとめ買いキャンペーン実施中Amazon.co.jp |
SponsoredSponsored
Undo
The 15 Least Obedient Dog BreedsWomentales.com |
SponsoredSponsored
Undo
MOST POPULAR
The awful truth of donating a dead body to “science”Quartz
Undo
MOST POPULAR
Ex-Trump lawyer Michael Cohen says he unwittingly sent AI-generated fake legal cases to his attorneyQuartz
Undo
花粉に！速攻！夜飲めば１日中効果続く！コンタック |
SponsoredSponsored
Undo
花粉症対策に、医療用と同成分・同量配合。口が渇きにくい！コンタック |
SponsoredSponsored
Undo
The World’s Most Stunning Blue Flag Beaches Ranked: Top 25 List!12facts.com |
SponsoredSponsored
Click Here
Undo